drugset / Trial / NCT05351840

To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers

NCT05351840 ↗

Phase 1 Completed 31 enrolled JW Pharmaceutical
RandomizedSequentialOpen-labelOther

Summary

To evaluate and compare the pharmacokinetic interactions and safety of multiple dose of Treatment A and Treatment B alone and in combination

Timeline

Start
2020-11-02
Primary completion
2020-12-19
Completion
2021-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject A Unknown — Oral
Subject LivaloV Unknown — Oral
Subject LivaloVA Unknown — Oral

Indications

No indication recorded.